Mycophenolic Acid
Selective Immunosuppressants
Sold as MYFORTIC
- Drug class
- Selective Immunosuppressants
- Availability
- See label
- Routes
- Oral
- Markets covered
- 2
- Products on record
- 10
Overview
Mycophenolic Acid is an active pharmaceutical ingredient in the Selective Immunosuppressants group (L04AA). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| CA Canada | Health Canada | 8 | February 12, 2026 |
| GB United Kingdom | MHRA | 2 | May 1, 2026 |
CACanada· Health Canada
8 products
Uses
APO-MYCOPHENOLIC ACID (mycophenolate sodium) is indicated for: • the prophylaxis of organ rejection in patients receiving allogeneic renal transplants, administered in combination with cyclosporine, and corticosteroids. 1 Pediatrics Safety and efficacy in pediatric patients have not been established.
3 Pharmacokinetics, Special Populations and Conditions, Pediatrics). 2 Geriatrics Patients > 65 years may generally be at increased risk of adverse drug reactions due to an immunosuppression. Based on the controlled mycophenolate sodium clinical trials, patients > 65 receiving mycophenolate sodium as part of a combination immunosuppressive regimen, did not show an increased risk of adverse reactions, compared to younger patients.
No dose adjustment is required in this patient population.
GBUnited Kingdom· MHRA
2 products
Uses
Mycophenolic acid is indicated in combination with ciclosporin and corticosteroids for the prophylaxis of acute transplant rejection in adult patients receiving allogeneic renal transplants.
How to take
Drug interactions
Known interactions involving Mycophenolic Acid. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 256. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]Health Canada (DPD) · 02372738 · revised September 18, 2025
- [2]MHRA (UK) · PL200750391 · revised May 1, 2026
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.